A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Carbimazole, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Carbimazole impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Carbimazole-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Carbimazole Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Carbimazole-d3 Stable Isotopes CS-O-10701 22232-54-8 (Unlabeled) In Stock
Carbimazole-d5 Stable Isotopes CS-O-13469 22232-54-8(Unlabeled) Enquire


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Carbimazole API Standards CS-O-01238 22232-54-8 In Stock


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Carbimazole EP Impurity A Impurities CS-O-05356 60-56-0 Enquire
Chlordiazepoxide Oxime Impurity Impurities CS-T-02287 18097-52-4 In Stock


EP Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Carbimazole (C0465000) EP Standards CS-EG-00784 22232-54-8 Enquire
Carbimazole (C0465000) EP Standards CS-EG-00774 22232-54-8 Enquire